220 related articles for article (PubMed ID: 26827257)
1. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder.
Bentzley JP; Tomko RL; Gray KM
J Subst Abuse Treat; 2016 Apr; 63():72-7. PubMed ID: 26827257
[TBL] [Abstract][Full Text] [Related]
2. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
[TBL] [Abstract][Full Text] [Related]
3. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
Gray KM; Carpenter MJ; Baker NL; DeSantis SM; Kryway E; Hartwell KJ; McRae-Clark AL; Brady KT
Am J Psychiatry; 2012 Aug; 169(8):805-12. PubMed ID: 22706327
[TBL] [Abstract][Full Text] [Related]
4. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.
McClure EA; Sonne SC; Winhusen T; Carroll KM; Ghitza UE; McRae-Clark AL; Matthews AG; Sharma G; Van Veldhuisen P; Vandrey RG; Levin FR; Weiss RD; Lindblad R; Allen C; Mooney LJ; Haynes L; Brigham GS; Sparenborg S; Hasson AL; Gray KM
Contemp Clin Trials; 2014 Nov; 39(2):211-23. PubMed ID: 25179587
[TBL] [Abstract][Full Text] [Related]
5. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.
Tomko RL; Gilmore AK; Gray KM
Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870
[TBL] [Abstract][Full Text] [Related]
6. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
[TBL] [Abstract][Full Text] [Related]
7. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.
Squeglia LM; Tomko RL; Baker NL; McClure EA; Book GA; Gray KM
Drug Alcohol Depend; 2018 Apr; 185():17-22. PubMed ID: 29413434
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents.
McClure EA; Baker NL; Gray KM
Am J Drug Alcohol Abuse; 2014 Jul; 40(4):285-91. PubMed ID: 24720376
[TBL] [Abstract][Full Text] [Related]
9. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study.
McClure EA; Baker NL; Sonne SC; Ghitza UE; Tomko RL; Montgomery L; Babalonis S; Terry GE; Gray KM
Drug Alcohol Depend; 2018 Nov; 192():59-66. PubMed ID: 30218864
[TBL] [Abstract][Full Text] [Related]
10. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
Squeglia LM; Baker NL; McClure EA; Tomko RL; Adisetiyo V; Gray KM
Addict Behav; 2016 Dec; 63():172-7. PubMed ID: 27521979
[TBL] [Abstract][Full Text] [Related]
11. N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study.
Cullen KR; Klimes-Dougan B; Westlund Schreiner M; Carstedt P; Marka N; Nelson K; Miller MJ; Reigstad K; Westervelt A; Gunlicks-Stoessel M; Eberly LE
J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):136-144. PubMed ID: 29053023
[TBL] [Abstract][Full Text] [Related]
12. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder.
Lee DC; Schlienz NJ; Herrmann ES; Martin EL; Leoutsakos J; Budney AJ; Smith MT; Tompkins DA; Hampson AJ; Vandrey R
J Subst Use Addict Treat; 2024 Jan; 156():209180. PubMed ID: 37802317
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial interventions for cannabis use disorder.
Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
[TBL] [Abstract][Full Text] [Related]
15. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
[TBL] [Abstract][Full Text] [Related]
16. N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials.
Sharma R; Tikka SK; Bhute AR; Bastia BK
Addict Behav; 2022 Jun; 129():107283. PubMed ID: 35189496
[TBL] [Abstract][Full Text] [Related]
17. Contingency management improves smoking cessation treatment outcomes among highly impulsive adolescent smokers relative to cognitive behavioral therapy.
Morean ME; Kong G; Camenga DR; Cavallo DA; Carroll KM; Pittman B; Krishnan-Sarin S
Addict Behav; 2015 Mar; 42():86-90. PubMed ID: 25462659
[TBL] [Abstract][Full Text] [Related]
18. Levels of impulsivity in individuals with cannabis use disorder.
Wagner MF; Oliveira CR; Paloski LH
Trends Psychiatry Psychother; 2022 Jul; 44(suppl 1):e20210449. PubMed ID: 35500250
[TBL] [Abstract][Full Text] [Related]
19. Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial.
McRae-Clark AL; Gray KM; Baker NL; Sherman BJ; Squeglia L; Sahlem GL; Wagner A; Tomko R
Drug Alcohol Depend; 2021 Dec; 229(Pt B):109111. PubMed ID: 34655945
[TBL] [Abstract][Full Text] [Related]
20. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.
Roten AT; Baker NL; Gray KM
Addict Behav; 2013 Mar; 38(3):1788-91. PubMed ID: 23261493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
